gene	transcript	isCanonical	event	eventIsHighDriver	germline	reported	treatment	onLabel	level	direction	sources
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Cobimetinib + Vemurafenib	true	A	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=FDA|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Dabrafenib	true	A	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=FDA|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Dabrafenib + Trametinib	true	A	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25399551|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=FDA|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Trametinib	true	A	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=FDA|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Vemurafenib	true	A	RESPONSIVE	vicc_cgi|BRAF BRAF:V600G||HOTSPOT_MUTATION||https://www.google.com/#q=NCCN|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=FDA|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21639808|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	RO4987655	true	B	RESPONSIVE	vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/24947927|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Bevacizumab	false	B	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19603024,http://www.ncbi.nlm.nih.gov/pubmed/19571295|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	CI-1040	false	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/18682506,http://www.ncbi.nlm.nih.gov/pubmed/21882184|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Cetuximab	false	B	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19884556,http://www.ncbi.nlm.nih.gov/pubmed/19001320,http://www.ncbi.nlm.nih.gov/pubmed/25666295,http://www.ncbi.nlm.nih.gov/pubmed/20619739|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21163703,http://www.ncbi.nlm.nih.gov/pubmed/23325582,http://www.ncbi.nlm.nih.gov/pubmed/20619739|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Cetuximab + Irinotecan + Vemurafenib	false	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27729313|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Fluorouracil	false	B	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19603024|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Irinotecan	false	B	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19603024|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Oxaliplatin	false	B	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19603024|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Panitumumab	false	B	RESISTANT	vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/23325582|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19001320|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21163703,http://www.ncbi.nlm.nih.gov/pubmed/23325582,http://www.ncbi.nlm.nih.gov/pubmed/20619739|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Selumetinib	false	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22492957|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	true	Sorafenib	false	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/18682506,http://www.ncbi.nlm.nih.gov/pubmed/21882184|;
PTEN	ENST00000371953	true	partial loss	true	false	true	Buparlisib + Carboplatin + Paclitaxel	true	B	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/25672916|;
PTEN	ENST00000371953	true	partial loss	true	false	true	Anti-EGFR monoclonal antibody	false	B	RESISTANT	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/21163703,http://www.ncbi.nlm.nih.gov/pubmed/19398573|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/21163703,http://www.ncbi.nlm.nih.gov/pubmed/19398573|;
PTEN	ENST00000371953	true	partial loss	true	false	true	Cetuximab	false	B	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/21163703|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Chemotherapy	false	B	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/15900596|;
PTEN	ENST00000371953	true	partial loss	true	false	true	Everolimus	false	B	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/23989949|;
PTEN	ENST00000371953	true	partial loss	true	false	true	Lapatinib + Trastuzumab	false	B	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/25300346|;
PTEN	ENST00000371953	true	partial loss	true	false	true	Trastuzumab	false	B	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/24387334|;vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/20813970|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib	false	A	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=NCCN|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Trametinib	false	A	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27283860|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27283860|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	false	A	RESPONSIVE	vicc_cgi|BRAF BRAF:V600G||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26287849|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26287849|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cobimetinib + Vemurafenib	true	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25265494|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib	true	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22735384|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21343559|;vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/22608338|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Trametinib	true	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24583796|;vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/23020132|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Trametinib	true	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22663011|;vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/22663011|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	true	B	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24508103,http://www.ncbi.nlm.nih.gov/pubmed/26557775,http://www.ncbi.nlm.nih.gov/pubmed/25524477,http://www.ncbi.nlm.nih.gov/pubmed/20818844,http://www.ncbi.nlm.nih.gov/pubmed/23569304,http://www.ncbi.nlm.nih.gov/pubmed/25399551|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22356324|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Trametinib	false	B	RESPONSIVE	vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/26392102|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	false	B	RESPONSIVE	vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/26287849|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27460442|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22492957,http://www.ncbi.nlm.nih.gov/pubmed/20068183,http://www.ncbi.nlm.nih.gov/pubmed/21274720|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26352686|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26200454|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	false	B	RESISTANT	vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/26287849|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Bay	true	C	RESISTANT	vicc_civic|BRAF V600||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/23434733|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Pictilisib	true	C	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25370471|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Raffinose	true	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=ESMO 2015 (abstract 300),https://www.google.com/#q=AACR 2017 (abstr  CT002),https://www.google.com/#q=AACR 2016 (abstr CT005)|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	true	C	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24463458,http://www.ncbi.nlm.nih.gov/pubmed/24616537|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	2-butanone	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22241789,https://www.google.com/#q=ASCO 2013 (abstr 9029)|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Braf	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22608338|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cetuximab	false	C	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19603018,http://www.ncbi.nlm.nih.gov/pubmed/19603024,http://www.ncbi.nlm.nih.gov/pubmed/26989027|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cetuximab + Irinotecan + Mab + Vemurafenib	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF (V600)||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/27729313|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23489023,https://www.google.com/#q=ESMO 2014 (abstr LBA38_PR),http://www.ncbi.nlm.nih.gov/pubmed/22608338,https://www.google.com/#q=ASCO 2013 (abstr 8009),http://www.ncbi.nlm.nih.gov/pubmed/23524406,http://www.ncbi.nlm.nih.gov/pubmed/20818844,http://www.ncbi.nlm.nih.gov/pubmed/27080216|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22608338,http://www.ncbi.nlm.nih.gov/pubmed/23470635|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib	false	C	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23524406|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Mab + Panitumumab	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF (V600)||CODON_MUTATION|600|https://www.google.com/#q=ENA 2014 (abstr 11LBA)|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Mab + Panitumumab + Trametinib	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=ASCO 2014 (abstr 3515),https://www.google.com/#q=ASCO 2015 (abstr 103)|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Trametinib	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26392102,https://www.google.com/#q=ASCO 2015 (abstr 8006)|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27048246|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib + Trametinib + Vemurafenib	false	C	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27048246|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Egfr	false	C	RESISTANT	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22773810|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Glu-arg-lys	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=ASCO 2017 (abstr 2508)|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Irinotecan	false	C	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19603018|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Mab	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF (V600)||CODON_MUTATION|600|http://www.ncbi.nlm.nih.gov/pubmed/28363909|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Panitumumab + Vemurafenib	false	C	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27325282|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Selumetinib	false	C	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=NCT01089101|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	false	C	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22621641,http://www.ncbi.nlm.nih.gov/pubmed/23300174,http://www.ncbi.nlm.nih.gov/pubmed/23278307,http://www.ncbi.nlm.nih.gov/pubmed/25815361,http://www.ncbi.nlm.nih.gov/pubmed/27116997|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22586120|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24821190|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24335681|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/27520988|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24997557|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26287849|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23733758,http://www.ncbi.nlm.nih.gov/pubmed/24888229,http://www.ncbi.nlm.nih.gov/pubmed/26776917|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26286452|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25524464,http://www.ncbi.nlm.nih.gov/pubmed/26579623|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23489023,http://www.ncbi.nlm.nih.gov/pubmed/24987354,http://www.ncbi.nlm.nih.gov/pubmed/25353071|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23489023,http://www.ncbi.nlm.nih.gov/pubmed/20818844,http://www.ncbi.nlm.nih.gov/pubmed/22608338|;vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22621641,http://www.ncbi.nlm.nih.gov/pubmed/23612012,http://www.ncbi.nlm.nih.gov/pubmed/22743296|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24725538|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25092772|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25209580|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26490654|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	0325901	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/16424035,http://www.ncbi.nlm.nih.gov/pubmed/16273091|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Braf	true	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22389471,http://www.ncbi.nlm.nih.gov/pubmed/21156289|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Braf + Cdk2	true	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22997239|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Braf + Hsp90	true	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22351686|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cobimetinib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23934108|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dabrafenib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21107320,http://www.ncbi.nlm.nih.gov/pubmed/16424035,http://www.ncbi.nlm.nih.gov/pubmed/20818844,http://www.ncbi.nlm.nih.gov/pubmed/21107323|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dactolisib + Nvp + Selumetinib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26678033|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dasatinib	true	D	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19671763|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Glu-arg-lys	true	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22997239,http://www.ncbi.nlm.nih.gov/pubmed/23614898|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Gsk	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/16424035|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Selumetinib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/18172275,http://www.ncbi.nlm.nih.gov/pubmed/16424035|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Sorafenib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/16424035,http://www.ncbi.nlm.nih.gov/pubmed/15781657|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Trametinib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/16424035|;vicc_civic|BRAF MUTATION||ACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22169769|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	true	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22241959,http://www.ncbi.nlm.nih.gov/pubmed/18287029,http://www.ncbi.nlm.nih.gov/pubmed/20551065,http://www.ncbi.nlm.nih.gov/pubmed/26070258,http://www.ncbi.nlm.nih.gov/pubmed/21107323,http://www.ncbi.nlm.nih.gov/pubmed/21107320,http://www.ncbi.nlm.nih.gov/pubmed/16424035,http://www.ncbi.nlm.nih.gov/pubmed/20149136|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	true	D	RESISTANT	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/24576830|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	0325901	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19010912|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	0879 + Dactolisib + Gdc + Nvp	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23549875|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	119	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21351275|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	2-butanone	false	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19018267|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	957054-30-7 + Plx-4720	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23845441|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Bevacizumab + Capecitabine + Vemurafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22180495|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Braf	false	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22038996,http://www.ncbi.nlm.nih.gov/pubmed/22586120|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cetuximab	false	D	RESISTANT	vicc_civic|BRAF MUTATION||ACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22586653|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cetuximab + Gefitinib + Vemurafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22281684|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Cetuximab + Sorafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19001320|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Ci-1040	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/17911174|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Dasatinib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23729178|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Nutlin + Plx-4720	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/23812671|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Panitumumab + Sorafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/19001320|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Plx-4720	false	D	RESPONSIVE	vicc_cgi|BRAF BRAF:V600E||HOTSPOT_MUTATION||https://www.google.com/#q=PMC3638050|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Regorafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/26865419|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Selumetinib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/20806365|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Sorafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/16533790|;
BRAF	ENST00000288602	true	p.Val600Glu	true	false	false	Vemurafenib	false	D	RESPONSIVE	vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22038996|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/25706985|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/18458053|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/22448344,http://www.ncbi.nlm.nih.gov/pubmed/22180495|;vicc_civic|BRAF V600E||HOTSPOT_MUTATION||http://www.ncbi.nlm.nih.gov/pubmed/21185263,http://www.ncbi.nlm.nih.gov/pubmed/26456083|;
CDKN2A	ENST00000498124	true	p.Ala68fs	true	false	false	Cdk4	true	C	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||https://www.google.com/#q=ASCO 2013 (abstr 2500)|;
CDKN2A	ENST00000498124	true	p.Ala68fs	true	false	false	Ilorasertib	true	C	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||https://www.google.com/#q=NCT02478320|;
CDKN2A	ENST00000498124	true	p.Ala68fs	true	false	false	Cdk4	true	D	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22711607,http://www.ncbi.nlm.nih.gov/pubmed/22586120,http://www.ncbi.nlm.nih.gov/pubmed/22471707|;
CDKN2A	ENST00000498124	true	p.Ala68fs	true	false	false	Cdk4	false	D	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22711607,http://www.ncbi.nlm.nih.gov/pubmed/22586120,http://www.ncbi.nlm.nih.gov/pubmed/22471707|;
CDKN2A	ENST00000579755	false	p.Gly83fs	true	false	false	Cdk4	true	C	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||https://www.google.com/#q=ASCO 2013 (abstr 2500)|;
CDKN2A	ENST00000579755	false	p.Gly83fs	true	false	false	Ilorasertib	true	C	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||https://www.google.com/#q=NCT02478320|;
CDKN2A	ENST00000579755	false	p.Gly83fs	true	false	false	Cdk4	true	D	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22711607,http://www.ncbi.nlm.nih.gov/pubmed/22586120,http://www.ncbi.nlm.nih.gov/pubmed/22471707|;
CDKN2A	ENST00000579755	false	p.Gly83fs	true	false	false	Cdk4	false	D	RESPONSIVE	vicc_cgi|CDKN2A CDKN2A oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22711607,http://www.ncbi.nlm.nih.gov/pubmed/22586120,http://www.ncbi.nlm.nih.gov/pubmed/22471707|;
HDAC2	ENST00000519065	true	p.Arg409*	false	false	false	Olaparib	false	C	RESPONSIVE	vicc_cgi|HDAC2 HDAC2 biallelic inactivation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/26510020|;
PTEN	ENST00000371953	true	partial loss	true	false	false	1-tert-butyl-3-[6-(3 + 3-d]pyrimidin-7-yl]-urea + 5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2	true	C	RESPONSIVE	vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/26645196|;vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/26645196|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Sirolimus	true	C	RESPONSIVE	vicc_cgi|PTEN PTEN deletion||DELETION||https://www.google.com/#q=ASCO 2013 (abstr 2532)|;vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||https://www.google.com/#q=ASCO 2013 (abstr 2532)|;
PTEN	ENST00000371953	true	partial loss	true	false	false	10-decarboxymethylaclacinomycin t (dcmat)	false	C	RESPONSIVE	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/22025163|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/22025163|;
PTEN	ENST00000371953	true	partial loss	true	false	false	2206	false	C	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/22025163|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Byl-719	false	C	RESISTANT	vicc_cgi|PTEN PTEN biallelic inactivation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/25409150|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Cetuximab + Mab	false	C	RESISTANT	vicc_cgi|PTEN PTEN biallelic inactivation||INACTIVATION||https://www.google.com/#q=Caris molecular intelligence|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Everolimus	false	C	RESPONSIVE	vicc_civic|PTEN DELETION||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/23582881|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/23582881|;vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/27091708|;vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/23582881|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Mab + Panitumumab	false	C	RESISTANT	vicc_cgi|PTEN PTEN biallelic inactivation||INACTIVATION||https://www.google.com/#q=Caris molecular intelligence|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Parp inhibitors	false	C	RESPONSIVE	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/20944090,http://www.ncbi.nlm.nih.gov/pubmed/21468130|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/20944090,http://www.ncbi.nlm.nih.gov/pubmed/21468130|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Pik3cb	false	C	RESPONSIVE	vicc_cgi|PTEN PTEN deletion||DELETION||https://www.google.com/#q=ASCO 2014 (abstr 2514)|;vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||https://www.google.com/#q=ASCO 2014 (abstr 2514)|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Azd5363	true	D	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/22294718|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Ipatasertib	true	D	RESPONSIVE	vicc_civic|PTEN MUTATION||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/23287563|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Pi3k pathway inhibitors	true	D	RESPONSIVE	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/23136191,http://www.ncbi.nlm.nih.gov/pubmed/22662154,http://www.ncbi.nlm.nih.gov/pubmed/21289267,http://www.ncbi.nlm.nih.gov/pubmed/21191045,http://www.ncbi.nlm.nih.gov/pubmed/21325073,http://www.ncbi.nlm.nih.gov/pubmed/23287563,http://www.ncbi.nlm.nih.gov/pubmed/17804702,http://www.ncbi.nlm.nih.gov/pubmed/21673091,http://www.ncbi.nlm.nih.gov/pubmed/21632463,http://www.ncbi.nlm.nih.gov/pubmed/21998291,http://www.ncbi.nlm.nih.gov/pubmed/22932669,http://www.ncbi.nlm.nih.gov/pubmed/23085766|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/23136191,http://www.ncbi.nlm.nih.gov/pubmed/22662154,http://www.ncbi.nlm.nih.gov/pubmed/21289267,http://www.ncbi.nlm.nih.gov/pubmed/21191045,http://www.ncbi.nlm.nih.gov/pubmed/21325073,http://www.ncbi.nlm.nih.gov/pubmed/23287563,http://www.ncbi.nlm.nih.gov/pubmed/17804702,http://www.ncbi.nlm.nih.gov/pubmed/21673091,http://www.ncbi.nlm.nih.gov/pubmed/21632463,http://www.ncbi.nlm.nih.gov/pubmed/21998291,http://www.ncbi.nlm.nih.gov/pubmed/22932669,http://www.ncbi.nlm.nih.gov/pubmed/23085766|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Uprosertib	true	D	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/24735930|;
PTEN	ENST00000371953	true	partial loss	true	false	false	154447-36-6 + Trastuzumab	false	D	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/15324695|;
PTEN	ENST00000371953	true	partial loss	true	false	false	2-butanone	false	D	RESPONSIVE	vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/21632463|;vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/21632463|;
PTEN	ENST00000371953	true	partial loss	true	false	false	3'-azido-3'-deoxythymidine-5'-monophosphate	false	D	RESPONSIVE	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/27397505|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Alpelisib	false	D	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/25409150|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Alpelisib + Azd8186 + Enzalutamide	false	D	RESPONSIVE	vicc_civic|PTEN MUTATION||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/25544636|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Azd5363 + Docetaxel	false	D	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/24088382|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Azd8186	false	D	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/25398829|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Cisplatin	false	D	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/15790433|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Gdc + Taselisib	false	D	RESISTANT	vicc_civic|PTEN MUTATION||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/26589432|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Pi3k pathway inhibitor + ar antagonists	false	D	RESPONSIVE	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/21575859|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/21575859|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Pi3k pathway inhibitors	false	D	RESPONSIVE	vicc_cgi|PTEN PTEN oncogenic mutation||INACTIVATION||http://www.ncbi.nlm.nih.gov/pubmed/23136191,http://www.ncbi.nlm.nih.gov/pubmed/22662154,http://www.ncbi.nlm.nih.gov/pubmed/21289267,http://www.ncbi.nlm.nih.gov/pubmed/21191045,http://www.ncbi.nlm.nih.gov/pubmed/21325073,http://www.ncbi.nlm.nih.gov/pubmed/23287563,http://www.ncbi.nlm.nih.gov/pubmed/17804702,http://www.ncbi.nlm.nih.gov/pubmed/21673091,http://www.ncbi.nlm.nih.gov/pubmed/21632463,http://www.ncbi.nlm.nih.gov/pubmed/21998291,http://www.ncbi.nlm.nih.gov/pubmed/22932669,http://www.ncbi.nlm.nih.gov/pubmed/23085766|;vicc_cgi|PTEN PTEN deletion||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/23136191,http://www.ncbi.nlm.nih.gov/pubmed/22662154,http://www.ncbi.nlm.nih.gov/pubmed/21289267,http://www.ncbi.nlm.nih.gov/pubmed/21191045,http://www.ncbi.nlm.nih.gov/pubmed/21325073,http://www.ncbi.nlm.nih.gov/pubmed/23287563,http://www.ncbi.nlm.nih.gov/pubmed/17804702,http://www.ncbi.nlm.nih.gov/pubmed/21673091,http://www.ncbi.nlm.nih.gov/pubmed/21632463,http://www.ncbi.nlm.nih.gov/pubmed/21998291,http://www.ncbi.nlm.nih.gov/pubmed/22932669,http://www.ncbi.nlm.nih.gov/pubmed/23085766|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Temsirolimus	false	D	RESPONSIVE	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/23674493|;vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/11504908|;
PTEN	ENST00000371953	true	partial loss	true	false	false	Trastuzumab	false	D	RESISTANT	vicc_civic|PTEN LOSS||DELETION||http://www.ncbi.nlm.nih.gov/pubmed/17936563|;
